BJDX - Bluejay Diagnostics Inc logo

Bluejay Diagnostics Inc

BJDX

Bluejay Diagnostics develops medical diagnostics solutions using its Symphony platform, which features an analyzer and single-use protein detection cartridges for measuring key biomarkers in blood, including tests for IL-6, heart conditions, and critical care monitoring.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 1 year ago โ†’$66today

Score Overview

1 Year
Scoreโ€”
Net Growth-6.17%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-94.94%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Bluejay Diagnostics Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. BJDX does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-21
$ 0.68โ€”
1 Year2025-10-21
$ 10.24-93.40%
All Time2021-11-10
$ 170.24K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 0.00-$ 7M$ 9M
2025$ 0.00-$ 6M$ 5M
2024$ 0.00-$ 7M$ 4M
2023$ 0.00-$ 9M$ 2M
2022$ 249.04K-$ 9M$ 10M
IPO2021-$ 3M$ 19M
BJDX - Bluejay Diagnostics Inc logo

Bluejay Diagnostics Inc fundamental performance

Across Bluejay Diagnostics Inc's full reported history, from 2021 to 2025, net income went from -$ 3M to -$ 6M. Revenue increased in 0% of the years measured; net income in 40%.

Membership

Explore BJDX with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,118 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies